Rigel Pharmaceuticals reported $-27445000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agenus AGEN:US $ -50.6M 17M
Amgen AMGN:US $ 2727M 56M
Anika Therapeutics ANIK:US $ -3.71M 5.46M
Applied Genetic Technologies AGTC:US $ -14.24M 4.87M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Astrazeneca AZN:US $ 3709M 624M
Biomarin Pharmaceutical BMRN:US $ 26.19M 92.76M
Bristol Myers Squibb BMY:US $ 5386M 595M
Celldex Therapeutics CLDX:US $ -23.05M 2.9M
Chemocentryx CCXI:US $ -38.61M 1.92M
Daiichi Sankyo 4568:JP Y -52370M 92301M
Halozyme Therapeutics HALO:US $ 81.63M 20.43M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Immunogen IMGN:US $ -24.14M 13.03M
Intrexon XON:US $ -19.31M 5.71M
IONIS PHARMACEUT IONS:US $ -64M 289M
Karyopharm Therapeutics KPTI:US $ -41269000 79.87M
Macrogenics MGNX:US $ -66.44M 8.42M
Neurocrine Biosciences NBIX:US $ 21.4M 35.2M
Pfizer PFE:US $ 11328M 4083M
Regeneron Pharmaceuticals REGN:US $ 1119.1M 1986M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.74M
Sangamo Biosciences SGMO:US $ -43.92M 6.36M
Ultragenyx Pharmaceutical RARE:US $ -151.76M 29.32M
Veracyte VCYT:US $ -14.46M 3.15M